Understanding The Immune Environment in Metastatic Melanoma
-
Dr David Gyorki+61 3 8559 7666
Collaborators
A/Prof Michael Kershaw, Immune Innovation Laboratory Peter MacCallum Cancer Centre
A/Prof Phil Darcy, Immune Innovation Laboratory Peter MacCallum Cancer Centre
A/Prof Paul Neeson, Haematology and Immunology Translational Research Laboratory, Peter MacCallum Cancer Centre
Funding
Funded by grant from Peter MacCallum Foundation and philanthropic support
Research Outcomes
Reprogramming the tumor microenvironment to enhance adoptive cellular therapy.
Beavis PA, Slaney CY, Kershaw MH, Gyorki D, Neeson PJ, Darcy PK.
Semin Immunol. 2016 Feb;28(1):64-72. doi: 10.1016/j.smim.2015.11.003. Review.
The delicate balance of melanoma immunotherapy.
Gyorki DE, Callahan M, Wolchok JD, Ariyan CE.
Clin Transl Immunology. 2013 Aug 9;2(8):e5. doi: 10.1038/cti.2013.5. Review.
PMID: 25505953
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.
Gyorki DE, Yuan J, Mu Z, Zaidi B, Pulitzer M, Busam K, Brady MS, Coit DG, Allison JP, Wolchok JD, Ariyan CE.
Ann Surg Oncol. 2013 Sep;20(9):3106-11. doi: 10.1245/s10434-013-2999-1.
Research Group
Honorary Appointments’ Research Projects
Faculty Research Themes
School Research Themes
Key Contact
For further information about this research, please contact the research group leader.
Department / Centre
MDHS Research library
Explore by researcher, school, project or topic.